Blockchain Registration Transaction Record

VolitionRx Files Patent for Nu.Q Ebola Triage Test

VolitionRx files patent for Nu.Q Ebola triage test using nucleosome detection. Low-cost, rapid bedside solution for resource-constrained outbreak zones. Seeks partners for field trials.

This news matters because it addresses a critical gap in Ebola outbreak management: the need for rapid, low-cost triage tools in resource-limited settings. Volition's Nu.Q technology could enable early detection and monitoring of hyper-inflammation, potentially reducing mortality and improving outbreak containment. For global health agencies and NGOs, this partnership opportunity could lead to scalable solutions that save lives during future Ebola epidemics.